Acute promyelocytic leukemia surgery: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
(2 intermediate revisions by the same user not shown) | |||
Line 3: | Line 3: | ||
{{Acute promyelocytic leukemia}} | {{Acute promyelocytic leukemia}} | ||
{{CMG}}; {{AE}} | {{CMG}}; {{AE}} {{S.G.}} | ||
==Overview== | ==Overview== | ||
Line 10: | Line 10: | ||
==Indications== | ==Indications== | ||
*Surgical intervention is not recommended for the management of acute promyelocytic leukemia. | *Surgical intervention is not recommended for the management of acute promyelocytic leukemia.<ref name="pmid27713127">{{cite journal |vauthors=Huang J, Sun M, Wang Z, Zhang Q, Lou J, Cai Y, Chen W, Du X |title=Induction treatments for acute promyelocytic leukemia: a network meta-analysis |journal=Oncotarget |volume=7 |issue=44 |pages=71974–71986 |date=November 2016 |pmid=27713127 |pmc=5342137 |doi=10.18632/oncotarget.12451 |url=}}</ref> | ||
==Surgery== | ==Surgery== | ||
* | *Surgical intervention is not recommended for the management of acute promyelocytic leukemia.<ref name="pmid27713127" /> | ||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} |
Latest revision as of 17:44, 24 January 2019
Acute promyelocytic leukemia Microchapters |
Differentiating Acute promyelocytic leukemia from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Acute promyelocytic leukemia surgery On the Web |
American Roentgen Ray Society Images of Acute promyelocytic leukemia surgery |
Directions to Hospitals Treating Acute promyelocytic leukemia |
Risk calculators and risk factors for Acute promyelocytic leukemia surgery |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sogand Goudarzi, MD [2]
Overview
Surgical intervention is not recommended for the management of acute promyelocytic leukemia.
Indications
- Surgical intervention is not recommended for the management of acute promyelocytic leukemia.[1]
Surgery
- Surgical intervention is not recommended for the management of acute promyelocytic leukemia.[1]
References
- ↑ 1.0 1.1 Huang J, Sun M, Wang Z, Zhang Q, Lou J, Cai Y, Chen W, Du X (November 2016). "Induction treatments for acute promyelocytic leukemia: a network meta-analysis". Oncotarget. 7 (44): 71974–71986. doi:10.18632/oncotarget.12451. PMC 5342137. PMID 27713127.